Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Chronic Obstructive Pulmonary Disease|April 22, 2016
The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trialKristina Vermeersch, Maria Gabrovska, Griet Deslypere, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 7, 2020
Diagnostic performance of kSORT, a blood-based mRNA assay for noninvasive detection of rejection after kidney transplantation: A retrospective multicenter cohort studyElisabet Van Loon, Magali Giral, Dany Anglicheau, et al.
European Heart Journal|July 10, 2009
Reperfusion before percutaneous coronary intervention in ST-elevation myocardial infarction patients is associated with lower N-terminal pro-brain natriuretic peptide levels during follow-up, irrespective of pre-treatment with full-dose fibrinolysisPeter R Sinnaeve, Justin A Ezekowitz, Kris Bogaerts, et al.
American Heart Journal|January 28, 2010
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
Urologic Oncology|February 7, 2015
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvementLaura Van den Bergh, Evelyne Lerut, Karin Haustermans, et al.
Minerva Cardiology and Angiology|May 28, 2024
Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR RegistryDavid M Leistner, Rajiv Rampat, Michael Haude, et al.
Circulation. Cardiovascular Interventions|October 1, 2024
Comparison of Ultrathin- Versus Thin-Strut Stents in Patients With High Bleeding Risk PCI: Results From the COMPARE 60/80 HBR Trial: An Open-Label, Randomized, Controlled TrialPieter C Smits, Pim A L Tonino, Sjoerd H Hofma, et al.
Radiology|May 27, 2010
Middle ear cholesteatoma: non-echo-planar diffusion-weighted MR imaging versus delayed gadolinium-enhanced T1-weighted MR imaging--value in detectionBert De Foer, Jean-Philippe Vercruysse, Anja Bernaerts, et al.
European Heart Journal. Acute Cardiovascular Care|December 2, 2025
Rescue PCI in the Pharmaco-invasive Era of STEMI: Insights from the STREAM-2 TrialKevin R Bainey, Robert C Welsh, Yinggan Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 27, 2014
Individualized dosimetry-based activity reduction of ⁹⁰Y-DOTATOC prevents severe and rapid kidney function deterioration from peptide receptor radionuclide therapySofie Van Binnebeek, Kristof Baete, Bert Vanbilloen, et al.
Pageof 9